Veterinary Medicine Information website

KAOPECTATE SUSPENSION BUVABLE POUR EQUINS BOVINS OVINS PORCINS CHIENS ET CHATS

Authorised
  • KAOLIN, HEAVY
  • PECTIN

Product identification

Medicine name:
KAOPECTATE SUSPENSION BUVABLE POUR EQUINS BOVINS OVINS PORCINS CHIENS ET CHATS
Active substance:
  • KAOLIN, HEAVY
  • PECTIN
Target species:
  • Cattle (calf)
  • Horse (foal)
  • Pig (piglet)
  • Cat
  • Sheep (lamb)
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • KAOLIN, HEAVY
    197.20
    milligram(s)
    /
    1.00
    millilitre(s)
  • PECTIN
    4.40
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral suspension
Withdrawal period by route of administration:
  • Oral use
    • Cattle (calf)
      • Milk
        0
        day
      • Meat and offal
        0
        day
    • Horse (foal)
      • Milk
        0
        day
      • Meat and offal
        0
        day
    • Pig (piglet)
      • Meat and offal
        0
        day
    • Sheep (lamb)
      • Milk
        0
        day
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA07BC30
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Zoetis France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Purna Pharmaceuticals
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/2731701 3/1990
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 16/01/2024

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 15/10/2025